4//SEC Filing
HOWSON TAMAR D 4
Accession 0000899243-20-018612
CIK 0001262104other
Filed
Jul 6, 8:00 PM ET
Accepted
Jul 7, 1:12 PM ET
Size
6.6 KB
Accession
0000899243-20-018612
Insider Transaction Report
Form 4
MEI Pharma, Inc.MEIP
HOWSON TAMAR D
Director
Transactions
- Award
Stock Option (Right to Buy)
2020-07-02+50,000→ 50,000 totalExercise: $3.49Exp: 2030-07-02→ Common Stock (50,000 underlying)
Holdings
- 60,000
Stock Option (Right to Buy)
Exercise: $2.52Exp: 2029-07-01→ Common Stock (60,000 underlying)
Footnotes (2)
- [F1]The options will vest in equal monthly installments over twelve months.
- [F2]40,000 of the options vested on July 1, 2019 and currently exercisable and 20,000 options will vest in equal monthly installments over thirty-six months beginning July 1, 2019.
Documents
Issuer
MEI Pharma, Inc.
CIK 0001262104
Entity typeother
Related Parties
1- filerCIK 0001202286
Filing Metadata
- Form type
- 4
- Filed
- Jul 6, 8:00 PM ET
- Accepted
- Jul 7, 1:12 PM ET
- Size
- 6.6 KB